Results 1 to 10 of about 13,129 (133)

Oxidation of 7-dehydrocholesterol and desmosterol by human cytochrome P450 46A1[S] [PDF]

open access: yesJournal of Lipid Research, 2014
Cytochrome P450 (P450 or CYP) 46A1 is expressed in brain and has been characterized by its ability to oxidize cholesterol to 24S-hydroxycholesterol. In addition, the same enzyme is known to further oxidize 24S-hydroxycholesterol to the 24,25- and 24,27 ...
Sandeep Goyal   +4 more
doaj   +2 more sources

Desmosterol and 7-dehydrocholesterol concentrations in post mortem brains of depressed people: The role of trazodone [PDF]

open access: yesTranslational Psychiatry, 2022
Major depressive disorder (MDD) is a common, disabling, and heterogeneous condition that responds unpredictably to current treatments. We previously showed an association between depressive symptoms and plasma concentrations of two cholesterol precursors,
Basar Cenik   +6 more
doaj   +2 more sources

Radiation-induced ferroptosis via liposomal delivery of 7-Dehydrocholesterol [PDF]

open access: yesJournal of Nanobiotechnology
Background Ferroptosis is an emerging cell death mechanism characterized by uncontrolled lipid peroxidation. However, selectively inducing ferroptosis in cancer cells remains a challenge.
Jianwen Li   +17 more
doaj   +2 more sources

Identification and characterization of prescription drugs that change levels of 7-dehydrocholesterol and desmosterol [PDF]

open access: yesJournal of Lipid Research, 2018
Regulating blood cholesterol (Chol) levels by pharmacotherapy has successfully improved cardiovascular health. There is growing interest in the role of Chol precursors in the treatment of diseases.
Phillip A. Wages   +3 more
doaj   +2 more sources

7-Dehydrocholesterol attenuates osteoarthritis by synergistically inhibiting oxidative stress, inflammation, and ferroptosis in macrophages [PDF]

open access: yesFrontiers in Pharmacology
ObjectiveOsteoarthritis (OA) is a prevalent degenerative disorder affecting joints, characterized by progressive cartilage deterioration, inflammation of the synovium, and structural damage to subchondral bone.
Wenchao Zhang   +8 more
doaj   +2 more sources

On the formation of 7-ketocholesterol from 7-dehydrocholesterol in patients with CTX and SLO [PDF]

open access: yesJournal of Lipid Research, 2014
A new mechanism for formation of 7-ketocholesterol was recently described involving cytochrome P-450 (CYP)7A1-catalyzed conversion of 7-dehydrocholesterol into 7-ketocholesterol with cholesterol-7,8-epoxide as a side product.
Ingemar Björkhem   +11 more
doaj   +2 more sources

Detection of 7-Dehydrocholesterol and Vitamin D3 Derivatives in Honey [PDF]

open access: yesMolecules, 2020
20(S)-Hydroxyvitamin D3 (20(OH)D3) is an endogenous metabolite produced by the action of CYP11A1 on the side chain of vitamin D3 (D3). 20(OH)D3 can be further hydroxylated by CYP11A1, CYP27A1, CYP24A1 and/or CYP27B1 to several hydroxyderivatives. CYP11A1
Tae-Kang Kim   +6 more
doaj   +2 more sources

Metabolic engineering of Saccharomyces cerevisiae for 7-dehydrocholesterol overproduction [PDF]

open access: yesBiotechnology for Biofuels, 2018
Background 7-Dehydrocholesterol (7-DHC) has attracted increasing attentions due to its great medical value and the enlarging market demand of its ultraviolet-catalyzed product vitamin D3.
Xiao-Jing Guo   +7 more
doaj   +2 more sources

Inhibition of 7-dehydrocholesterol reductase prevents hepatic ferroptosis under an active state of sterol synthesis [PDF]

open access: yesNature Communications
Recent evidence indicates ferroptosis is implicated in the pathophysiology of various liver diseases; however, the organ-specific regulation mechanism is poorly understood.
Naoya Yamada   +19 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy